Acadian Asset Management
PTCT icon

Acadian Asset Management’s PTC Therapeutics PTCT Stock Holding History

Acadian Asset Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$613K Sell
7,525
-25,210
-77% -$1.82M ﹤0.01% 1391
2026
Q1 		$2.23M Sell
32,735
-36,769
-53% -$2.6M ﹤0.01% 922
2025
Q4 		$5.27M Buy
69,504
+45,354
+188% +$3.3M 0.01% 638
2025
Q3 		$1.48M Sell
24,150
-103,643
-81% -$5.4M ﹤0.01% 962
2025
Q2 		$6.23M Buy
127,793
+90,358
+241% +$4.29M 0.01% 530
2025
Q1 		$1.9M Buy
37,435
+2,140
+6% +$107K 0.01% 769
2024
Q4 		$1.59M Buy
35,295
+17,294
+96% +$740K ﹤0.01% 823
2024
Q3 		$667K Buy
18,001
+17,459
+3,221% +$584K ﹤0.01% 1018
2024
Q2 		$16K Buy
+542
New +$17.6K ﹤0.01% 1690
2023
Q4 		– Sell
-679
Closed -$15K – 1793
2023
Q3 		$15K Buy
+679
New +$25.3K ﹤0.01% 1572
2023
Q1 		– Sell
-539
Closed -$20K – 1921
2022
Q4 		$20K Sell
539
-822
-60% -$34.2K ﹤0.01% 1713
2022
Q3 		$68K Buy
+1,361
New +$66.7K ﹤0.01% 1444
2021
Q3 		– Sell
-1,464
Closed -$62K – 1960
2021
Q2 		$62K Buy
+1,464
New +$62.7K ﹤0.01% 1767
2018
Q3 		– Sell
-2,437
Closed -$82K – 1760
2018
Q2 		$82K Sell
2,437
-13,795
-85% -$430K ﹤0.01% 1290
2018
Q1 		$440K Buy
+16,232
New +$411K ﹤0.01% 890
2017
Q4 		– Sell
-11,762
Closed -$236K – 1655
2017
Q3 		$236K Buy
+11,762
New +$230K ﹤0.01% 883
2017
Q1 		– Sell
-25,421
Closed -$277K – 1728
2016
Q4 		$277K Buy
+25,421
New +$267K ﹤0.01% 961

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Acadian Asset Management's PTCT Position: Q2 2026 in Review

Acadian Asset Management reduced its PTC Therapeutics (PTCT) stake by 77% in Q2 2026, selling an estimated $1.82M and leaving 7,525 shares worth $613K. The position accounts for ﹤0.01% of the portfolio, ranked #1391.

Acadian Asset Management first reported a position in PTCT in Q4 2016 and has held it in 17 quarters since. The position peaked at $6.23M in Q2 2025. 287 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Acadian Asset Management held 7,525 shares of PTC Therapeutics worth $613K as of Q2 2026.
  • Acadian Asset Management sold 25,210 PTC Therapeutics shares in Q2 2026, an estimated $1.82M.
  • PTC Therapeutics made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #1391 holding.
  • Acadian Asset Management first reported a position in PTC Therapeutics in Q4 2016 and has held it in 17 quarters since.
  • Acadian Asset Management's PTC Therapeutics position peaked at $6.23M in Q2 2025.
  • 287 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.